Medical News

RSS

Patients with chronic hepatitis C can benefit by drinking coffee

Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers according to a new study led by Neal Freedman, Ph.D., MPH, from the National Cancer Institute (NCI).

20 Oct 2009

By protecting doctors' Medicare pay, lawmakers look to keep health reform tab low

The Los Angeles Times reports on a Democratic plan to cancel scheduled cuts to physician pay under the Medicare program with a bill separate from their sweeping health reform proposal. It would allow lawmakers to "reconcile a nearly $250-billion difference between the House and Senate" while at the same time keeping the American Medical Association on board with their plans.

20 Oct 2009

Covalon and Bard sign license agreement; Bard to apply Covalon's technology on its products

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSX VENTURE:COV), an advanced medical products company, announced that it has signed a License Agreement as well as a Services and Supply Agreement with a division of C. R. Bard, Inc.

20 Oct 2009

IPS examines potential for future U.N. population meeting

Inter Press Service examines the possibility of another U.N. conference on development and population within the next five years. Despite progress made since the 1994 conference on population and development (ICPD), U.N. Secretary-General Ban Ki-Moon recently noted more than 200 million women cannot access safe and effective contraception, and "too many women resort to unsafe abortions because they lack access to family planning," according to the news service.

20 Oct 2009

As HIV vaccine conference opens, experts appeal for sustained commitment to global fight against disease

Experts, gathered for the start of a four-day conference on HIV vaccines in Paris, called upon donors to maintain their funding support for the fight against HIV/AIDS despite the global economy, Agence France-Presse reports.

20 Oct 2009

Eclipsys supports healthcare providers to meet the goal of ARRA

To support healthcare organizations in making the appropriate technology decisions to maximize federal stimulus dollar opportunity, Eclipsys Corporation®, The Outcomes Company®, today announced the multiple superior outcomes its client organizations are achieving today.

20 Oct 2009

On-line portal for training doctors and nurses on fall prevention and protection

Medical Nurse Training, Inc. (www.MedicalNurseTraining.com) is the premier on-line portal for training doctors and nurses on fall prevention and protection.

20 Oct 2009

Positive results from KAI Pharmaceuticals' pain therapeutic program

KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, announced positive preclinical results from its program targeting the gamma protein kinase C (PKC) pathway for the development of novel therapies for pain.

20 Oct 2009

Tarsa Therapeutics receives license for Phase III oral calcitonin program

Unigene Laboratories, Inc. and Tarsa Therapeutics, Inc. today announced that Unigene has licensed its Phase III oral calcitonin program to Tarsa, a new company formed by a syndicate of three venture capital funds specializing in the life sciences: MVM Life Science Partners, Quaker BioVentures and Novo A/S.

20 Oct 2009

Children having accelerated bone growth at an increased risk of hypertension

Children whose bones are "older" than their chronological age may be at an increased risk of hypertension, according to a study reported today (19 October) in Hypertension: Journal of the American Heart Association.

20 Oct 2009

Positive data from BioSante Pharmaceuticals' LibiGel Phase III clinical development program

BioSante Pharmaceuticals, Inc., today announced positive safety data in its ongoing LibiGel Phase III clinical development program. For the first time, unblinded data have been reviewed by the independent DMC of the LibiGel Cardiovascular and Breast Cancer Safety Study. Based on this review of unblinded data, the DMC unanimously recommended continuation of the study as described in the study protocol, with no modifications.

20 Oct 2009

National Health Partners adds third marketing firm to its internet marketing campaign

National Health Partners, Inc. (National Health) (OTCBB: NHPR), a leading provider of unique discount healthcare membership programs, announced today that it has added a third leading marketing firm to its internet marketing campaign.

20 Oct 2009

Sojourns Award to recognize leadership in palliative care industry

The Regence Foundation has announced a new award that recognizes leadership in palliative care, a specialized field of health care that relieves suffering and improves quality of life for patients with advanced illness.

20 Oct 2009

Human Rights and Oversight to hold a hearing on international violence against women

On Wednesday, October 21 at 2:00 p.m. in Rayburn House Office Building, Room 2172, Chairman Delahunt (D-MA) of the House Foreign Affairs Subcommittee on International Organizations, Human Rights and Oversight will hold a hearing titled International Violence Against Women: Stories and Solutions.

20 Oct 2009

Targacept presents data from Phase 2b clinical trial of TC-5214

Targacept, Inc., a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics-, today announced the presentation of data from its recently completed Phase 2b clinical trial of TC-5214 as an augmentation (add-on) treatment in subjects with major depressive disorder, or MDD, who did not respond adequately to first-line treatment with the representative SSRI citalopram hydrobromide.

20 Oct 2009

FTC Red Flags Rule compliance with message encryption

With the deadline for compliance with the Federal Trade Commission's (FTC) Red Flags Rule looming, one Colorado Internet company is providing a simple solution -- encrypt your messages.

20 Oct 2009

Complimentary book for fertility patients placing first fertility cycle order

Village Fertility Pharmacy (www.villagefertilitypharmacy.com), a specialty pharmacy focused exclusively on infertility medications, is pleased to announce that, effectively immediately, fertility patients who place a fertility cycle order for the first time will receive a complimentary copy of Kristen Magnacca's award-winning book, "Love and Infertility: Strategies for Survival - Balancing Infertility, Marriage, and Life."

20 Oct 2009

Brandeis psychologist receives the 2009 Baltes Foundation Award

The Gerontological Society of America (GSA) - the nation's largest interdisciplinary organization devoted to the field of aging - has chosen Brandeis University Professor Derek M. Isaacowitz, as the 2009 recipient of the Margret M. & Paul B. Baltes Foundation Award in Behavioral and Social Gerontology.

20 Oct 2009

Human neural stem cells protect cone photoreceptors: StemCells preclinical data

StemCells, Inc. announced today new preclinical data showing that its human neural stem cells protect cone photoreceptors (cones) in the eye from progressive degeneration and preserve visual function long term.

20 Oct 2009

Report: National investment on childhood and adolescent cancer research

The first-ever detailed examination of a country's investment in research on childhood and adolescent cancers was released today by the Canadian Cancer Research Alliance (CCRA) and the Canadian Partnership Against Cancer (the Partnership).

20 Oct 2009